James Schuermann Insider Sell
The Heartware International Inc’s SVP - Sales & Marketing, James Schuermann, an insider made a sale of - 1,000 Heartware International Inc’s shares, based on the stock price per share of $53.0 for each share. The shares had a value of about $53,012 USD. A document freely available here disclosed this deal activity. It was disclosed on October 02, 2015 and filled with U.S. Security and Exchange Commission. James Schuermann now indirectly owns 0 shares. He also directly owns 9980 shares. In total he holds a stake of 0.06%.
Heartware International Inc Sentiment and Fundamentals
According to the fifteen stock analysts that cover the fundamentals of Heartware International Inc, we should expect to see earnings reach $-2.10 per share in 2015. This will give it PE ratio of around NaN & growth rate year on year of -20.25%.
We too rate the -listed Heartware International Inc’s stock a sell mainly because of our well-know equities momentum model as illustrated below. Heartware International Inc’s stock chart indicates it has dived 22.04% in the last 200 days and the reliable down trend is expected to continue.
Institutional Ownership
Information from Q2 2015 SEC filings, show 113 institutional investors holded Heartware International Inc. The institutional ownership of this company in Q2 2015 is high, at 110.89% of the shares outstanding. Its up 1.88% from Q1 2015. These institutional players and asset managers increased the total shares they own by 354,180 to 19.18 million this quarter. There were 9 funds that closed their positions and 32 that reduced them. A total of 13 funds opened new positions in Heartware International Inc and 47 increased their holdings.
William Leland Edwards’s Palo Alto Investors Llc is the most bullish hedge fund on Heartware International Inc, with ownership of 243,868 shares as of Q2 2015 for 0.79% of the fund’s portfolio. William Michaelcheck’s Mariner Investment Group Llc is another bullish asset manager possessing 45,000 shares of the company or 0.84% of their stocks portfolio. The stock is also 0.01% of the fund’s AUM. In addition Rock Springs Capital Management Lp have 0.86% of their stock portfolio invested in the company’s market cap for 162,000 shares. Jerome Pfund And Michael Sjostrom’s Sectoral Asset Management Inc disclosed it had acquired a stake worth 0.54% of the fund’s stock portfolio in Heartware International Inc. Manning & Napier Advisors Llc is also an optimist about the public company, with ownership of 653,020 shares or 0.21% of their stock portfolio.
HeartWare International NASDAQ:HTWR Company Profile
Heartware International, Inc. is a medical device company. The Company develops and manufactures miniaturized implantable heart pumps or ventricular assist devices for patients suffering from advanced heart failure. The HeartWare Ventricular Assist System (HVAD System), which includes a ventricular assist device (VAD) or blood pump, patient accessories and surgical tools, provides circulatory support for patients in the advanced stage of heart failure. The core of the HVAD System is a continuous flow blood pump, the HVAD pump. The HVAD System is designed to be implanted adjacent to the heart, avoiding abdominal surgery, directly adjacent to the heart. The Company’s hybrid system is used for suspending the impeller. The impeller is suspended within the pump housing by the opposing forces of passive magnets and hydrodynamic thrust generated by the pump impeller, which circulates a cushion of blood.
Company Website: HeartWare International
Heartware International Inc was formed in Delaware on 2008-07-29. The company has 585 employees. At the moment its market capitalization is: $936.45 million and it has 17.67 million shares outstanding. At the moment it has 114.94% shareholders and the institutional ownership stands at 114.94%. The stock closed at $54.130001 yesterday and it had average 2 days volume of 135212 shares. It is down from the 30 days average shares volume of 149005. Heartware International Inc has a 52w low of $50.25 and a 52w high of $95.29. The current price is below the 200 days simple moving average. Heartware International Inc last issued its quarterly earnings data on 07/30/2015. The company reported -0.47 EPS for the quarter, missing the consensus estimate of -0.46 by 0.01. The company had a revenue of 73.57 million for 6/30/2015 and 70.02 million for 3/31/2015. Therefore, the revenue was 3.55 million up.
* These shares were sold pursuant to a pre-arranged trading plan in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
* The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $52.18 to $53.11. The reporting person has provided the issuer and will provide any security holder of the issuer or the SEC Staff - upon request - information regarding the number of shares sold at each price within the range.
* The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $53.24 to $53.64. The reporting person has provided the issuer and will provide any security holder of the issuer or the SEC Staff - upon request - information regarding the number of shares sold at each price within the range.
